ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada
· Delayed Price · Currency is CAD 0.700
0.00 (0.00%)
At close: Dec 5, 2025
ZYUS Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -33.74 | -33.81 | -42.59 | -24.66 | -23.46 | -25.09 |
| Depreciation & Amortization | 2.89 | 2.96 | 3.11 | 3.06 | 2.52 | 1.36 |
| Other Amortization | - | - | - | 0.98 | 1.26 | 0.06 |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.24 |
| Asset Writedown & Restructuring Costs | 19.2 | 19.2 | 22.77 | 2.09 | - | 3.24 |
| Stock-Based Compensation | 0.21 | 0.41 | 0.27 | 0.11 | 0.62 | 1.56 |
| Other Operating Activities | 0.76 | -0.33 | 3.25 | 6.22 | 0.03 | 0.03 |
| Change in Accounts Receivable | 0.01 | 0.26 | -0.35 | 0.11 | 0.33 | 0.68 |
| Change in Inventory | 0.4 | 0.32 | -0.02 | 0.45 | -0.17 | -4.87 |
| Change in Accounts Payable | -0.86 | 0.7 | -5.12 | 2.34 | 1.93 | 3.71 |
| Change in Other Net Operating Assets | 0.4 | 0.4 | 0.74 | -0.27 | 0.08 | -1.12 |
| Operating Cash Flow | -10.73 | -9.88 | -17.95 | -9.57 | -16.86 | -20.68 |
| Capital Expenditures | -0.01 | -0.05 | -0.28 | -0.56 | -4.99 | -5.45 |
| Sale of Property, Plant & Equipment | 0.03 | - | - | - | - | 0.29 |
| Cash Acquisitions | - | - | 4.92 | -0.03 | - | - |
| Sale (Purchase) of Intangibles | - | - | - | - | -0 | -0.52 |
| Investment in Securities | - | 1.87 | -0.06 | - | - | - |
| Investing Cash Flow | 0.02 | 1.83 | 4.58 | -0.59 | -4.99 | -5.68 |
| Short-Term Debt Issued | - | 0.7 | 0.35 | 3.04 | - | - |
| Long-Term Debt Issued | - | 5 | 20.89 | 6.76 | 11.63 | 10.99 |
| Total Debt Issued | 11.04 | 5.7 | 21.24 | 9.8 | 11.63 | 10.99 |
| Short-Term Debt Repaid | - | -0.6 | -3.09 | -0.1 | - | - |
| Long-Term Debt Repaid | - | -2.44 | -1.02 | -0.24 | -0.03 | -0.45 |
| Total Debt Repaid | -0.31 | -3.04 | -4.11 | -0.34 | -0.03 | -0.45 |
| Net Debt Issued (Repaid) | 10.73 | 2.66 | 17.14 | 9.45 | 11.6 | 10.54 |
| Issuance of Common Stock | - | 3.31 | - | 0.18 | 3.01 | 0.16 |
| Financing Cash Flow | 10.73 | 5.97 | 17.14 | 9.63 | 14.61 | 14.68 |
| Net Cash Flow | 0.02 | -2.08 | 3.77 | -0.54 | -7.24 | -11.68 |
| Free Cash Flow | -10.74 | -9.92 | -18.23 | -10.13 | -21.85 | -26.13 |
| Free Cash Flow Margin | -2309.46% | -2062.79% | -5193.45% | -3400.67% | -10553.14% | - |
| Free Cash Flow Per Share | -0.14 | -0.14 | -0.33 | -0.26 | -0.43 | -0.54 |
| Cash Interest Paid | 0 | 0.17 | 0.23 | 0.11 | 0.9 | 0.13 |
| Levered Free Cash Flow | -5.68 | -3.78 | -14.89 | -5.66 | -12.36 | - |
| Unlevered Free Cash Flow | -4.69 | -3.3 | -12.85 | -2.38 | -11.45 | - |
| Change in Working Capital | -0.05 | 1.69 | -4.75 | 2.62 | 2.17 | -1.6 |
Source: S&P Capital IQ. Standard template. Financial Sources.